Lo Andrew sold BBIO
November 17, 2025 · Form 4 insider transaction
Lo Andrew sold 36,801 shares of BridgeBio Pharma, Inc. at $66.63 per share, a transaction worth $2.45M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
36,801
Price
$66.63
Total value
$2.45M
InsiderLo Andrew
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateNovember 17, 2025
Filing dateNovember 19, 2025
Shares owned after17,887
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents the weighted average sale price of the shares sold from $65.975 to $66.97 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.